4-6-2007
HEMA and Lion Capital ready for future growth
Amsterdam, 1 June 2007. Maxeda B.V. (“Maxeda”) and Lion Capital LLP (“Lion Capital”) today announce that an agreement has been reached through which Lion Capital will acquire HEMA B.V. (“HEMA”). The acquisition is subject to a request for advice submitted to the Works Councils and to the approval of the relevant
Competition Authorities.
HEMA has a strong record of profitable growth as well as excellent prospects and
experienced management. HEMA is a leader in its core markets, and is reaping the
benefits from recent investments and improved business fundamentals. Sales and
profitability have grown consistently over the past three years. Gross sales grew
notably to more than EUR 1.3 billion in 2006 with annual double digit operating profit
growth. HEMA has approximately 10.000 employees.